AstraZeneca
Senior Scientist, Viral Vector Process Development (Upstream) at AstraZeneca supporting the Cell Therapy modalities portfolio, focused on development of suspension lentiviral vector processes for clinical and commercial scales. The role sits at the interface of research and CMC, supporting progression from research through IND-enabling activities and collaborating with internal teams and external CDMOs. This position is based in Gaithersburg, MD.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
Senior Scientist, Viral Vector Process Development, Upstream
American Association of Physicists in Medicine
Sr. Scientist - Viral Vector Expression (Biotechnology Discovery Research)
Eli Lilly and Company
Exec Director, Viral Vector Process Development
Gilead Sciences
Senior Research Associate – Scientist II, Molecular Biology & Viral Vector Platforms
Adicet Bio
Senior Scientist-LVV, Process Development
American Association of Physicists in Medicine
Scientist I/II, Viral Vector Process Development
Asimov